Brief fixation enables same-day breast cancer diagnosis with reliable assessment of hormone receptors, E-cadherin and HER2/Neu
- 21 March 2017
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 70 (9) , 781-786
Abstract
Aims Preoperative core needle biopsy (CNB) is commonly used to confirm the diagnosis of breast cancer. For treatment purposes and for determining histological type, especially in case of neoadjuvant therapy, oestrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) status and E-cadherin assessments are crucial. Considering the increasing demand for same-day diagnosis of breast lesions, an accelerated method of CNB processing was developed, in which the tissue fixation time is radically reduced. Methods To determine whether short fixation time frustrates assessment of ER, PR and E-cadherin immunohistochemistry (IHC) and HER2 fluorescence in situ hybridisation (FISH), 69 consecutive patients with 70 invasive breast carcinomas were included through the same-day diagnostics programme of breast lesions of the Radboud university medical center and the hospital Pantein. IHC for ER, PR and E-cadherin and HER2 FISH were compared between CNBs fixed for approximately 60–90 min and traditionally fixed resection specimens. Results Overall agreement between CNBs and resection specimens was 98.6% for ER (pConclusions Hormone receptors and E-cadherin IHC and HER2 FISH are highly comparable between briefly fixed CNBs and the corresponding traditionally fixed resection specimens, and can therefore reliably be used in the daily clinical practice of same-day diagnostics of breast cancer.Keywords
This publication has 32 references indexed in Scilit:
- E-Cadherin Expression: A Diagnostic Utility for Differentiating Breast Carcinomas with Ductal and Lobular MorphologiesJournal of Clinical and Diagnostic Research, 2013
- Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysisBreast Cancer Research and Treatment, 2012
- Quantitative assessment shows loss of antigenic epitopes as a function of pre-analytic variablesLaboratory Investigation, 2011
- The Effect of Delay in Fixation, Different Fixatives, and Duration of Fixation in Estrogen and Progesterone Receptor Results in Breast CarcinomaAmerican Journal of Clinical Pathology, 2011
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast CancerJournal of Clinical Oncology, 2010
- Fixation Time Does Not Affect the Expression of Estrogen ReceptorAmerican Journal of Clinical Pathology, 2010
- Accurately Assessing HER-2/neu Status in Needle Core Biopsies of Breast Cancer Patients in the Era of Neoadjuvant Therapy: Emerging Questions and Considerations AddressedAmerican Journal of Surgical Pathology, 2010
- The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breastJournal of Clinical Pathology, 2006
- Reliance on Hormone Receptor Assays of Surgical Specimens May Compromise Outcome in Patients With Breast CancerJournal of Clinical Oncology, 2005
- Differential Expression of E-Cadherin in Lobular and Ductal Neoplasms of the Breast and Its Biologic and Diagnostic ImplicationsAmerican Journal of Clinical Pathology, 2001